Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2026-06-15 18:22:01 ET · period of report 2026-06-11 · accession 0001493152-26-028753 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 18:22 | 2026-06-11 | IMDX | Arno Andrew | Dir | A - Grant | $0.00 | +32.3K | 168.9K | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2026-06-11 | A | A | 32,331 | $0.00 | 168,885 | D | — | — | (F1) The Restricted Stock Units shall vest on the date of the next annual meeting of shareholders, subject to the Reporting Person's continued service from the date of grant until the vesting date. |